Washington-based Seagen bought by Pfizer for $43B, boosts access to cancer drugs

Deutschland Nachrichten Nachrichten

Washington-based Seagen bought by Pfizer for $43B, boosts access to cancer drugs
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 komonews
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Bothell, Washington-based Seagen Inc. specializes in working with antibody-drug conjugate, or ADC, technology.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

komonews /  🏆 272. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Pfizer buys Seagen for $43B, boosts access to cancer drugsPfizer buys Seagen for $43B, boosts access to cancer drugsPfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 per Seagen share.
Weiterlesen »

Pfizer to buy Seagen for $43B to enhance reach of cancer drugsPfizer to buy Seagen for $43B to enhance reach of cancer drugsDrugmaker seeks out new revenue sources as expiration of patents protecting drugs like Ibrance from competition nears.
Weiterlesen »

Pfizer buys Seagen for $43B, boosts access to cancer drugsPfizer buys Seagen for $43B, boosts access to cancer drugsPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Weiterlesen »

Pfizer to pay $43B for Seagen, boosting cancer drug portfolioPfizer to pay $43B for Seagen, boosting cancer drug portfolioThe latest deal comes as Pfizer seeks to mitigate an anticipated $17 billion hit to revenue by 2030 from patent expirations for top drugs and decline in demand for its COVID products.
Weiterlesen »

Pfizer buys Seagen for $43B, boosts access to cancer drugsPfizer buys Seagen for $43B, boosts access to cancer drugsPfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The company said it will pay $229 in cash for each Seagen share, combining Seagen’s technology with Pfizer’s scale and strength, Pfizer's CEO said in a statement.
Weiterlesen »

Pfizer buys Bothell’s Seagen for $43B, boosts access to cancer drugsPfizer buys Bothell’s Seagen for $43B, boosts access to cancer drugsPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Weiterlesen »



Render Time: 2025-02-28 21:22:04